CoChat

RETRACTED ARTICLE: Periostin secreted by cancer-associated fibroblasts promotes cancer stemness in head and neck cancer by activating protein tyrosine kinase 7

Open access
Yu, Binbin, Wu, Kailiu, Wang, Xu, Zhang, Jianjun, Wang, Lizhen, Jiang, Yingying, Zhu, Xueqin, Chen, Wantao, Yan, Ming · 2018 · Cell Death & Disease
Cited by 121

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Protein tyrosine kinase 7 (PTK7) and cancer-associated fibroblasts (CAFs) play important roles in cancer stemness, respectively. However, little is known about interaction between CAFs and PTK7 in cancers. In this study, we showed that PTK7 was significantly correlated with the Wnt/β-Catenin pathway and aggressive clinicopathologic features in human head and neck squamous cell carcinoma (HNSCC). Meanwhile, animal experiments showed that PTK7 enhanced chemoresistance and lung metastasis of HNSCC in vivo. In addition, co-immunoprecipitation (co-IP) assay demonstrated that POSTN secreted by CAFs was a potential upstream ligand of PTK7 which might act as a receptor. Further analysis revealed that POSTN promoted the cancer stem cell (CSC)-like phenotype via PTK7–Wnt/β-Catenin signaling, including the proliferation and invasion of HNSCC cells in vitro, as well as tumor initiation and progression in vivo. Collectively, our study proved that CAF-derived POSTN might promote cancer stemness via interacting with PTK7 in HNSCC, suggesting that the combination of POSTN and PTK7 might be a potential prognostic and diagnostic indicator and a promising therapeutic target.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41419-018-1116-6This paper is marked retracted.

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 60

  1. Torre, L. A. et al. 1 Global cancer statistics, 2012. CA Cancer J. Clin. 65, 87–108 (2015). · DOI · Paper page
  2. D’Cruz, A. K. et al. Elective versus therapeutic neck dissection in node-negative oral cancer. N. Engl. J. Med. 373, 521–529 (2015). · doi:10.1056/nejmoa1506007
  3. Chen, D. et al. Targeting BMI1(+) cancer stem cells overcomes chemoresistance and inhibits metastases in squamous cell carcinoma. Cell Stem Cell 20, 621–634.e626 (2017). · DOI · Paper page
  4. Li, P. et al. CRB3 downregulation confers breast cancer stem cell traits through TAZ/beta-catenin. Oncogenesis 6, e322 (2017). · DOI
  5. Li, C. et al. CD54-NOTCH1 axis controls tumor initiation and cancer stem cell functions in human prostate cancer. Theranostics 7, 67–80 (2017). · DOI
  6. Brabletz, T., Jung, A., Spaderna, S., Hlubek, F. & Kirchner, T. Opinion: migrating cancer stem cells—an integrated concept of malignant tumour progression. Nat. Rev. Cancer 5, 744–749 (2005). · DOI · Paper page
  7. Yan, M. et al. Plasma membrane proteomics of tumor spheres identify CD166 as a novel marker for cancer stem-like cells in head and neck squamous cell carcinoma. Mol. Cell Proteomics 12, 3271–3284 (2013). · DOI
  8. Jung, P. et al. Isolation of human colon stem cells using surface expression of PTK7. Stem Cell Rep. 5, 979–987 (2015). · DOI · Paper page
  9. Liu, Q. et al. PTK7 regulates Id1 expression in CD44-high glioma cells. Neuro-Oncol. 17, 505–515 (2015). · doi:10.1093/neuonc/nou227
  10. Dong, Y. et al. PTK7 is a molecular marker for metastasis, TNM stage, and prognosis in oral tongue squamous cell carcinoma. Pol. J. Pathol. 68, 49–54 (2017). · doi:10.5114/pjp.2017.67615
  11. Puppo, F. et al. Protein tyrosine kinase 7 has a conserved role in Wnt/beta-catenin canonical signalling. EMBO Rep. 12, 43–49 (2011). · DOI
  12. Hayes, M. et al. ptk7 mutant zebrafish models of congenital and idiopathic scoliosis implicate dysregulated Wnt signalling in disease. Nat. Commun. 5, 4777 (2014). · DOI · Paper page
  13. Hayes, M., Naito, M., Daulat, A., Angers, S. & Ciruna, B. Ptk7 promotes non-canonical Wnt/PCP-mediated morphogenesis and inhibits Wnt/beta-catenin-dependent cell fate decisions during vertebrate development. Development 140, 1807–1818 (2013). · DOI
  14. Berger, H., Wodarz, A. & Borchers, A. PTK7 faces the Wnt in development and disease. Front. Cell Dev. Biol. 5, 31 (2017). · DOI · Paper page
  15. Bin-Nun, N. et al. PTK7 modulates Wnt signaling activity via LRP6. Development 141, 410–421 (2014). · DOI
  16. Xian, L. et al. HMGA1 amplifies Wnt signalling and expands the intestinal stem cell compartment and Paneth cell niche. Nat. Commun. 8, 15008 (2017). · DOI
  17. Kim, J. H., Park, S. Y., Jun, Y., Kim, J. Y. & Nam, J. S. Roles of Wnt target genes in the journey of cancer stem cells. Int. J. Mol. Sci. 18, E1604 (2017). · DOI · Paper page
  18. Fu, L. et al. Wnt2 secreted by tumour fibroblasts promotes tumour progression in oesophageal cancer by activation of the Wnt/beta-catenin signalling pathway. Gut 60, 1635–1643 (2011). · DOI
  19. Xu, X. et al. Periostin expression in intra-tumoral stromal cells is prognostic and predictive for colorectal carcinoma via creating a cancer-supportive niche. Oncotarget 7, 798–813 (2016). · DOI
  20. Oskarsson, T. & Massague, J. Extracellular matrix players in metastatic niches. EMBO J. 31, 254–256 (2012). · DOI
  21. Cui, D., Huang, Z., Liu, Y. & Ouyang, G. The multifaceted role of periostin in priming the tumor microenvironments for tumor progression. Cell. Mol. Life Sci. 74, 4287–4291 (2017). · DOI
  22. Bao, S. et al. Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway. Cancer Cell. 5, 329–339 (2004). · DOI · Paper page
  23. Shi, Y., Ping, Y. F., Zhang, X. & Bian, X. W. Hostile takeover: glioma stem cells recruit TAMs to support tumor progression. Cell Stem Cell 16, 219–220 (2015). · DOI
  24. Zhang, R. et al. Activated hepatic stellate cells secrete periostin to induce stem cell-like phenotype of residual hepatocellular carcinoma cells after heat treatment. Sci. Rep. 7, 2164 (2017). · DOI
  25. Malanchi, I. et al. Interactions between cancer stem cells and their niche govern metastatic colonization. Nature 481, 85–89 (2011). · DOI · Paper page
  26. Zhang, F. et al. Periostin: a downstream mediator of EphB4-induced osteogenic differentiation of human bone marrow-derived mesenchymal stem cells. Stem Cells Int. 2016, 7241829 (2016). · DOI
  27. Lv, J. et al. Involvement of periostin-sclerostin-Wnt/beta-catenin signaling pathway in the prevention of neurectomy-induced bone loss by naringin. Biochem. Biophys. Res. Commun. 468, 587–593 (2015). · DOI
  28. Qin, X. et al. TGFbeta3-mediated induction of Periostin facilitates head and neck cancer growth and is associated with metastasis. Sci. Rep. 6, 20587 (2016). · DOI · Paper page
  29. Lee, T. K. et al. CD24(+) liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation. Cell Stem Cell 9, 50–63 (2011). · DOI · Paper page
  30. Lin, C. et al. Elevated RET expression enhances EGFR activation and mediates EGFR inhibitor resistance in head and neck squamous cell carcinoma. Cancer Lett. 377, 1–10 (2016). · DOI
  31. Ma, H. et al. Interferon-alpha enhances the antitumour activity of EGFR-targeted therapies by upregulating RIG-I in head and neck squamous cell carcinoma. Br. J. Cancer 118, 509–521 (2018). · DOI
  32. Yao, M. et al. Phase II study of erlotinib and docetaxel with concurrent intensity-modulated radiotherapy in locally advanced head and neck squamous cell carcinoma. Head. Neck 38(Suppl. 1), E1770–E1776 (2016).
  33. Morra, L. & Moch, H. Periostin expression and epithelial-mesenchymal transition in cancer: a review and an update. Virchows Arch. 459, 465–475 (2011). · DOI · Paper page
  34. Tian, B., Zhang, Y. & Zhang, J. Periostin is a new potential prognostic biomarker for glioma. Tumour Biol. 35, 5877–5883 (2014). · DOI
  35. Gross, A. M. & Orosco, R. K. Multi-tiered genomic analysis of head and neck cancer ties TP53 mutation to 3p loss. Nat. Genet. 46, 939–943 (2014). · DOI
  36. Chen, G., Yan, M., Li, R. R. & Chen, W. T. Sonic hedgehog signalling activation contributes to ALCAM over-expression and poor clinical outcome in patients with oral squamous cell carcinoma. Chin. J. Dent. Res. 21, 31–40 (2018).
  37. Wang, C., Liu, X. Q., Hou, J. S., Wang, J. N. & Huang, H. Z. Molecular mechanisms of chemoresistance in oral cancer. Chin. J. Dent. Res. 19, 25–33 (2016).
  38. Tian, X. et al. PTK7 overexpression in colorectal tumors: clinicopathological correlation and prognosis relevance. Oncol. Rep. 36, 1829–1836 (2016). · DOI
  39. Lin, Y. et al. PTK7 as a novel marker for favorable gastric cancer patient survival. J. Surg. Oncol. 106, 880–886 (2012). · doi:10.1002/jso.23154
  40. Gartner, S. et al. PTK 7 is a transforming gene and prognostic marker for breast cancer and nodal metastasis involvement. PLoS ONE 9, e84472 (2014). · DOI
  41. Jin, J., Ryu, H. S., Lee, K. B. & Jang, J. J. High expression of protein tyrosine kinase 7 significantly associates with invasiveness and poor prognosis in intrahepatic cholangiocarcinoma. PLoS ONE 9, e90247 (2014). · DOI
  42. Golubkov, V. S. & Strongin, A. Y. Downstream signaling and genome-wide regulatory effects of PTK7 pseudokinase and its proteolytic fragments in cancer cells. Cell Commun. Signal. 12, 15 (2014). · doi:10.1186/1478-811x-12-15
  43. Chen, R. et al. A meta-analysis of lung cancer gene expression identifies PTK7 as a survival gene in lung adenocarcinoma. Cancer Res. 74, 2892–2902 (2014). · DOI · Paper page
  44. Damelin, M. et al. A PTK7-targeted antibody-drug conjugate reduces tumor-initiating cells and induces sustained tumor regressions. Sci. Transl. Med. 9, pii: eaag2611 (2017). · DOI · Paper page
  45. Katoh, M. Canonical and non-canonical WNT signaling in cancer stem cells and their niches: cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review). Int. J. Oncol. 51, 1357–1369 (2017). · DOI · Paper page
  46. Mittal, V. et al. The microenvironment of lung cancer and therapeutic implications. Adv. Exp. Med. Biol. 890, 75–110 (2016). · DOI
  47. Labernadie, A. et al. A mechanically active heterotypic E-cadherin/N-cadherin adhesion enables fibroblasts to drive cancer cell invasion. Nat. Cell Biol. 19, 224–237 (2017). · DOI · Paper page
  48. Marsh, T., Pietras, K. & McAllister, S. S. Fibroblasts as architects of cancer pathogenesis. Biochim. Biophys. Acta 1832, 1070–1078 (2013). · DOI · Paper page
  49. Ostman, A. & Augsten, M. Cancer-associated fibroblasts and tumor growth--bystanders turning into key players. Curr. Opin. Genet. Dev. 19, 67–73 (2009). · DOI · Paper page
  50. Zhang, F. et al. Periostin upregulates Wnt/beta-catenin signaling to promote the osteogenesis of CTLA4-modified human bone marrow-mesenchymal stem cells. Sci. Rep. 7, 41634 (2017). · DOI
  51. Bonnet, N., Conway, S. J. & Ferrari, S. L. Regulation of beta catenin signaling and parathyroid hormone anabolic effects in bone by the matricellular protein periostin. Proc. Natl. Acad. Sci. USA 109, 15048–15053 (2012). · DOI · Paper page
  52. Boras-Granic, K. & Wysolmerski, J. J. Wnt signaling in breast organogenesis. Organogenesis 4, 116–122 (2008). · DOI
  53. Ma, J., Lu, W., Chen, D., Xu, B. & Li, Y. Role of Wnt co-receptor LRP6 in triple negative breast cancer cell migration and invasion. J. Cell Biochem. 118, 2968–2976 (2017). · DOI
  54. Tammela, T. et al. A Wnt-producing niche drives proliferative potential and progression in lung adenocarcinoma. Nature 545, 355–359 (2017). · DOI · Paper page
  55. Yan, K. S. et al. Non-equivalence of Wnt and R-spondin ligands during Lgr5(+) intestinal stem-cell self-renewal. Nature 545, 238–242 (2017). · DOI · Paper page
  56. Janda, C. Y. et al. Surrogate Wnt agonists that phenocopy canonical Wnt and beta-catenin signalling. Nature 545, 234–237 (2017). · DOI · Paper page
  57. Ruan, K., Bao, S. & Ouyang, G. The multifaceted role of periostin in tumorigenesis. Cell. Mol. Life Sci. 66, 2219–2230 (2009). · DOI · Paper page
  58. Wu, X. et al. TGM3, a candidate tumor suppressor gene, contributes to human head and neck cancer. Mol. Cancer 12, 151 (2013). · DOI
  59. Budwit-Novotny, D. A. et al. Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody. Cancer Res. 46, 5419–5425 (1986).
  60. Azim, H. A. Jr et al. RANK-ligand (RANKL) expression in young breast cancer patients and during pregnancy. Breast Cancer Res. 17, 24 (2015). · DOI · Paper page

Cited by

See all 121

Metadata

Authors
Yu, B., Wu, K., Wang, X., Zhang, J., Wang, L., Jiang, Y., Zhu, X., Chen, W., & Yan, M.
Venue
Cell Death & Disease
Published
2018-10-22
Volume
9
Issue
11
Pages
1082-1082
ISSN
2041-4889 (ISSN-L)
OpenAlex
W2896101912
Cited by
121
References
6
FWCI
3.79
Type
journal article
Language
en
Status
Retracted
Open access
gold
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: RETRACTED ARTICLE: Periostin secreted by cancer-associated fibroblasts promotes cancer stemness in head and neck cancer by activating protein tyrosine kinase 7. https://app.cochat.ai/papers/10.1038/s41419-018-1116-6
The paper
Yu, B., Wu, K., Wang, X., Zhang, J., Wang, L., Jiang, Y., Zhu, X., Chen, W., & Yan, M. (2018). RETRACTED ARTICLE: Periostin secreted by cancer-associated fibroblasts promotes cancer stemness in head and neck cancer by activating protein tyrosine kinase 7. Cell Death & Disease. https://doi.org/10.1038/s41419-018-1116-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.